These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2499554)

  • 1. Serotonin as a modulator of skeletal muscle oxygenation: effects of ketanserin and ritanserin on oxygen pressure distributions.
    Thorborg P; Lund N
    Int J Microcirc Clin Exp; 1989 Apr; 8(2):191-203. PubMed ID: 2499554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hyperoxemia and ritanserin on skeletal muscle microflow.
    Thorborg P; Gustafsson U; Sjöberg F; Harrison DK; Lewis DH
    J Appl Physiol (1985); 1990 Apr; 68(4):1494-500. PubMed ID: 2112127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface oxygen pressure distributions in rabbit skeletal muscle: dependence on arterial pO2.
    Thorborg P; Malmqvist LA; Lund N
    Microcirc Endothelium Lymphatics; 1988 Apr; 4(2):169-92. PubMed ID: 3374446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin--one possible link between oxygen metabolism and the regulation of blood flow in the brain?
    Gustafsson U; Sjöberg F
    Int J Microcirc Clin Exp; 1996; 16(3):143-6. PubMed ID: 8856388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striated muscle tissue oxygenation and lactate levels during normo-, hyper- and hypocapnia. A study in the rabbit.
    Thorborg P; Jorfeldt L; Löfström JB; Lund N
    Microcirc Endothelium Lymphatics; 1988 Jun; 4(3):205-29. PubMed ID: 3138518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hypoxic hypoxia and ritanserin on capillary flow and oxygenation in rabbit skeletal muscle.
    Gustafsson U; Sjöberg F; Lewis DH; Thorborg P
    Acta Physiol Scand; 1994 Jan; 150(1):39-45. PubMed ID: 8135122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
    Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
    Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketanserin and ritanserin can reduce reperfusion-induced but not ischaemia-induced arrhythmias in anaesthetised rats.
    Coker SJ; Ellis AM
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):479-84. PubMed ID: 2444803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ritanserin and serotonergic mechanisms in blood pressure and fluid regulation in sheep.
    Nelson M; Coghlan JP; Denton DA; Tresham JJ; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1987 Jul; 14(7):555-63. PubMed ID: 3124998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension.
    Hosie J; Stott DJ; Robertson JI; Ball SG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S86-8. PubMed ID: 2446081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of ketanserin with baroreflex control of the circulation in the conscious spontaneously hypertensive rat.
    Smits J; van Dorsten F; Struyker Boudier H
    Drugs; 1988; 36 Suppl 1():55-60. PubMed ID: 3149239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone and serotonin receptor subtype antagonists: interactive effects upon deprivation-induced intake.
    Beczkowska IW; Bodnar RJ
    Pharmacol Biochem Behav; 1991 Mar; 38(3):605-10. PubMed ID: 1906186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of flufylline, fluprofylline, ritanserin, butanserin and R 56413 with respect to in-vivo alpha 1-,alpha 2- and 5-HT2-receptor antagonism and in-vitro affinity for alpha 1-,alpha 2- and 5-HT2-receptors: comparison with ketanserin.
    Korstanje C; Sprenkels R; Doods HN; Hugtenburg JG; Boddeke E; Batink HD; Thoolen MJ; Van Zwieten PA
    J Pharm Pharmacol; 1986 May; 38(5):374-9. PubMed ID: 2872314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists.
    Rashid M; Watanabe M; Nakazawa M; Nakamura T; Hattori K; Nagatom T
    Jpn J Pharmacol; 2001 Nov; 87(3):189-94. PubMed ID: 11885967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative haemodynamic effects of ketanserin and ritanserin in the proximal and distal upper limb circulations of hypertensive patients.
    Chau NP; Pithois-Merli I; Levenson J; Simon AC
    Eur J Clin Pharmacol; 1989; 37(3):215-20. PubMed ID: 2533074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial and venous effects of serotonin in the forearm of healthy subjects are not age-related.
    Blauw GJ; van Brummelen P; Chang PC; Vermeij P; van Zwieten PA
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):14-21. PubMed ID: 2475705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb.
    Jandhyala BS; Kivlighn SD
    Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists-LY53857, sergolexole, and LY237733.
    McBride PA; Mann JJ; Nimchinsky E; Cohen ML
    Life Sci; 1990; 47(23):2089-95. PubMed ID: 2125095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.